Research of radiotherapy combined with cisplatin and 5-lfuorouraci concurrent chemoradiotherapy on locally advanced esophageal carcinoma
- VernacularTitle:放疗联合顺铂+氟尿嘧啶方案同步化疗治疗局部晚期食管癌的实效性探究
- Author:
Xiaoxiang WANG
- Publication Type:Journal Article
- Keywords:
esophageal carcinoma;
chemoradiotherapy;
cisplatin;
5-lfuorouraci
- From:
Chinese Journal of Biochemical Pharmaceutics
2014;(2):76-78
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the efficacy of radiotherapy combined with cisplatin and 5-fluorouraci concurrent chemoradiotherapy on locally advanced esophageal carcinoma. Methods 80 cases with locally advanced esophageal carcinoma collected in our hospital from September 2002 to December 2011 were divided into combination group and radiotherapy group, each had 40 cases. Patients of combination group were given radiotherapy combined with DDP and 5-FU, while radiotherapy group were only adopted radiation therapy. The efifcacy and the safety of the therapy methods were evaluated. Results The treatment effect of the chemoradiotherapy on locally advanced esophageal carcinoma was obvious. The efifcacy of combination group was 90.0%, and radiotherapy was only 72.5%, the difference was signiifcant(P<0.01). The survival rate of combination group was 33%, higher than 24.4%of radiotherapy group. The adverse reactions of combination group were higher than radiotherapy group, but most of which were light, and could be eliminated after active treatment. Conclusion The radiotherapy combined with DDP and 5-FU can enhance the efifcacy and survival rate of patients with locally advanced esophageal carcinoma, and also cause an increase in adverse reactions, which can be controlled effectively.
